Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 17
665
Views
5
CrossRef citations to date
0
Altmetric
Review

The Malaysian genus Calophyllum (Calophyllaceae): a review on its phytochemistry and pharmacological activities

, , &
Pages 4569-4579 | Received 01 Apr 2021, Accepted 11 Sep 2021, Published online: 12 Oct 2021
 

Abstract

Genus Calophyllum from the family of Calophyllaceae is an evergreen broad-leaved tree that is endemic to Southeast Asia, especially Malaysia. They have been reported for various ethnomedicinal uses in traditional medicine. Previous studies of Malaysian Calophyllum species revealed them to be a rich source of bioactive phytoconstituents such as xanthones, coumarins, terpenoids, and chromanone acids. To date, the extracts and compounds from Malaysian Calophyllum species have shown a broad spectrum of pharmacological activities. For example, calanolide A, a coumarin isolated from Malaysian C. lanigerum, has now reached clinical development to become an anti-HIV drug. This article presents an overview of the significant phytochemical and pharmacological activities of Malaysian Calophyllum species to aid researchers in further discovery of potential benefits of various species of this genus.

Graphical Abstract

Acknowledgements

AADZ and TK thanks the Director of Centre for Drug Research, Prof Dr. B.Vicknasingam and Universiti Sains Malaysia for providing the facilities for the present review study. AADZ is a recipient of GRA-Assist (2020) for master programme during the course of present study.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.